Site updated at Wednesday, 22 June 2016

Living with Dementia

Alzheimer Treatment

India’s Piramal buys Bayer’s potential Alzheimer drug

Indian drugmaker Piramal Healthcare has agreed to buy a research and development portfolio from Bayer AG, the company said, in a deal that gives Piramal rights to florbetaben, a possible Alzheimer treatment.

Florbetaben, which is in the final stages of clinical trials, works by detecting symptoms in probable sufferers of Alzheimer’s, and is expected… India’s Piramal buys Bayer’s potential Alzheimer drug   

I have Alzheimer Disease

early-onset alzheimer's disease1 - cognitive dysfunction4 - als1 - alzheimer’s vaccine1 - exelon1 - pseudogeneral paralysis1 - postitron emission tomography1 - nilotinib1 - journal of alzheimer's disease2 - difficulties with swallowing1 - degenerative dementia2 - alzheimers patients3 - arts health institute1 - leg tremors1 - mediterranean diet1 - quality standards subcommittee1 - biomarkers of alzheimer's disease1 - alzheimer type2 - blood pressure6 - dsm iv3 - great mimicker1 - medical history1 - restlessness1 - vascular dementia13 - alzheimer's process1 - selective serotonin reuptake inhibitor2 - perchloroethylene1 - hearing1 - visuospatial deficits1 - risk of dementia12 -